naltrexone and Cancer of Digestive System

naltrexone has been researched along with Cancer of Digestive System in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conti, A; Kozlov, V; Laudon, M; Lissoni, P; Maestroni, G; Malugani, F; Malysheva, O	1

Trials

1 trial(s) available for naltrexone and Cancer of Digestive System

Article	Year
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system. Neuro endocrinology letters, 2002, Volume: 23, Issue:4 Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Digestive System Neoplasms; Female; Humans; Injections, Subcutaneous; Interleukin-2; Kidney Neoplasms; Male; Melatonin; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pilot Projects	2002

Article

Year

Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.

Neuro endocrinology letters, 2002, Volume: 23, Issue:4

Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Digestive System Neoplasms; Female; Humans; Injections, Subcutaneous; Interleukin-2; Kidney Neoplasms; Male; Melatonin; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pilot Projects

2002